United States · Platforms & data · Benzinga
Alpha Dart Therapy Shows Complete Tumor Clearance in Five Brain Cancer Patients

Detailed summary
Alpha Tau Medical Ltd. (NASDAQ:DRTS) on Sunday reported positive interim results from its U.S. REGAIN trial evaluating Alpha DaRT therapy in patients with recurrent…
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.benzinga.com)



